Apex Medical Corp. announced the change in Research and development officer Alan Chang, Vice President due to position adjustment transfer to the position of group's subsidiary, and As the periodic tasks are completed,the position will be closed, Effective May 31, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.05 TWD | +0.18% | -0.53% | -2.94% |
May. 15 | Wellell Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 18 | Wellell Inc. Appoints Su Ya-Ling as Chief Operating Officer | CI |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.94% | 87.26M | |
+1.58% | 1.47B | |
-9.91% | 1.33B | |
-4.89% | 1.22B | |
-26.95% | 766M | |
+1.67% | 459M | |
+1.70% | 431M | |
-62.86% | 266M | |
-32.42% | 299M | |
-0.08% | 218M |
- Stock Market
- Equities
- 4106 Stock
- News Wellell Inc.
- Apex Medical Corp. Announces Change of Alan Chang as Research and Development Officer, Effective May 31, 2022